| 000 | 01499 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513142841.0 | ||
| 264 | 0 | _c19980527 | |
| 008 | 199805s 0 0 eng d | ||
| 022 | _a0012-1797 | ||
| 024 | 7 |
_a10.2337/diabetes.47.5.810 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWalker, A B | |
| 245 | 0 | 0 |
_aDifferential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. _h[electronic resource] |
| 260 |
_bDiabetes _cMay 1998 |
||
| 300 |
_a810-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aAdipose Tissue _xblood supply |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aArteries _xdrug effects |
| 650 | 0 | 4 |
_aChromans _xpharmacology |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xdrug therapy |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Evaluation, Preclinical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aRosiglitazone |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 | _aThiazolidinediones |
| 650 | 0 | 4 | _aTroglitazone |
| 650 | 0 | 4 |
_aVasodilator Agents _xpharmacology |
| 700 | 1 | _aNaderali, E K | |
| 700 | 1 | _aChattington, P D | |
| 700 | 1 | _aBuckingham, R E | |
| 700 | 1 | _aWilliams, G | |
| 773 | 0 |
_tDiabetes _gvol. 47 _gno. 5 _gp. 810-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/diabetes.47.5.810 _zAvailable from publisher's website |
| 999 |
_c9555248 _d9555248 |
||